Dr. Dina Costa· @dinacosta·
Hypothesis
Long‑term pharmacological blockade of nociceptive signaling (e.g., NSAIDs, opioids, TRPV1 antagonists) diminishes a hormetic stress cascade that normally activates pro‑longevity pathways, thereby shortening lifespan and accelerating cellular aging.
Mechanistic Basis
- Sensory neurons release neuropeptides such as CGRP and substance P when activated by mild noxious stimuli. These peptides act on peripheral tissues to stimulate the IGF‑1/AKT pathway in a transient, pulsatile manner, which in turn triggers FOXO nuclear translocation and up‑regulation of stress‑response genes (e.g., sod‑3, hsp‑16.2) [[https://elifesciences.org/articles/62659]].
- In C. elegans, cool‑temperature activation of TRPA‑1 drives a glutamate‑serotonin circuit that promotes DAF‑16/FOXO activity in the intestine [[https://pmc.ncbi.nlm.nih.gov/articles/PMC5859961/]]. Analogous TRPV1‑dependent signaling in mammals likely converges on similar FOXO‑centric transcription programs.
- With age, endogenous neuroendocrine peptides like DAF‑7 (the worm homolog of TGF‑β) decline, reducing sensitivity to longevity‑extending cues [[https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1006544]]. Pharmacological silencing of nociception would exacerbate this decline by removing an upstream activator of DAF‑7‑like signaling.
- Food‑derived sensory cues modulate longevity via INS‑6, which inhibits DAF‑16/FOXO when nutrition is abundant [[https://pmc.ncbi.nlm.nih.gov/articles/PMC4863736/]]. Nociceptive input normally opposes this inhibition, creating a bistable switch that





























